Cargando…
Checkpoint CD47 Function On Tumor Metastasis And Immune Therapy
The success of cancer immunotherapy on recognition checkpoints for killing cancer cells has raised a great interest of scientists in understanding new and old methods of immunotherapeutic. CD47 (cluster of differentiation 47) is a cell surface glycoprotein and widely expressed on cells, which belong...
Autores principales: | Lian, Shu, Xie, Xiaodong, Lu, Yusheng, Jia, Lee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839575/ https://www.ncbi.nlm.nih.gov/pubmed/31806995 http://dx.doi.org/10.2147/OTT.S220196 |
Ejemplares similares
-
Is CD47 an innate immune checkpoint for tumor evasion?
por: Liu, Xiaojuan, et al.
Publicado: (2017) -
Dual blockage of both PD-L1 and CD47 enhances immunotherapy against circulating tumor cells
por: Lian, Shu, et al.
Publicado: (2019) -
Simultaneous blocking of CD47 and PD-L1 increases innate and adaptive cancer immune responses and cytokine release
por: Lian, Shu, et al.
Publicado: (2019) -
Targeting the CD47-SIRPα Innate Immune Checkpoint to Potentiate Antibody Therapy in Cancer by Neutrophils
por: Behrens, Leonie M., et al.
Publicado: (2022) -
The SIRPα–CD47 immune checkpoint in NK cells
por: Deuse, Tobias, et al.
Publicado: (2021)